Overview

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a multi center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.
Phase:
Phase 2
Details
Lead Sponsor:
BioPharmX, Inc.
Treatments:
Minocycline